The relationship between diabetes mellitus and Parkinson's disease.
暂无分享,去创建一个
[1] S. Aronson. INTRACRANIAL VASCULAR LESIONS IN PATIENTS WITH DIABETES MELLITUS , 1973, Journal of neuropathology and experimental neurology.
[2] R. Wurtman,et al. Brain Catechol Synthesis: Control by Brain Tyrosine Concentration , 1974, Science.
[3] T. Hayashi,et al. Studies on DOPA- and dopamine-hyperglycemia. , 1968, Bulletin of the Osaka Medical School.
[4] A. Hirano,et al. Alzheimer's neurofibrillary changes. A topographic study. , 1962, Archives of neurology.
[5] H. Lebovitz,et al. Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. , 1971, The Journal of clinical endocrinology and metabolism.
[6] R. Sandyk. Dopamine and insulin interact to modulate in vitro glucose transport in rat adipocytes. , 1988, The International journal of neuroscience.
[7] R. Sandyk. Increased incidence of neuroleptic-induced perioral movements in the rat by hyperglycemia. , 1990, The International journal of neuroscience.
[8] M. Pederzoli,et al. L‐dopa long‐term treatment in Parkinson's disease , 1983, Neurology.
[9] J W Langston,et al. The hypothalamus in parkinson disease , 1978, Annals of neurology.
[10] S. Iversen,et al. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.
[11] B. Campbell,et al. Potentiation of Amphetamine-induced Arousal by Starvation , 1971, Nature.
[12] J. Pierce. Edward e. David, jr., president-elect. , 1977, Science.
[13] Z. Lacković,et al. Effect of Long‐Lasting Diabetes Mellitus on Rat and Human Brain Monoamines , 1990, Journal of neurochemistry.
[14] M. Koulu,et al. Diabetes-induced alteration in brain monoamine metabolism in rats. , 1986, The Journal of pharmacology and experimental therapeutics.
[15] J. Marshall. Further analysis of the resistance of the diabetic rat to d-amphetamine , 1978, Pharmacology Biochemistry and Behavior.
[16] P. Johnson,et al. Thickened cerebral cortical capillary basement membranes in diabetics. , 1982, Archives of pathology & laboratory medicine.
[17] R. Sandyk,et al. Tardive dyskinesia and glucose metabolism. , 1986, Archives of general psychiatry.
[18] D. Schnur,et al. Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance , 1989, Psychiatry Research.
[19] S. Leu,et al. Alterations in Physiologic Functions and in Brain Monoamine Content in Streptozocin-Diabetic Rats , 1986, Diabetes.
[20] W. Weiner,et al. Textbook of clinical neuropharmacology , 1981 .
[21] R. Mackenzie,et al. Streptozotocin‐Induced Diabetes Reduces Brain Serotonin Synthesis in Rats , 1986, Journal of neurochemistry.
[22] J A Obeso,et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. , 1989, Neurology.
[23] H. Klawans. The pharmacology of tardive dyskinesias. , 1973, The American journal of psychiatry.
[24] L. Chiodo,et al. Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. , 1980, Science.
[25] I. Lipman,et al. Glucose intolerance in Parkinson's disease. , 1974, Journal of Chronic Diseases.
[26] S. Kay,et al. Risk factors for neuroleptic-induced movement disorders. , 1991, The International journal of neuroscience.
[27] R. D. Myers,et al. Striatal dopamine release is altered by glucose and insulin during push-pull perfusion of the rat's caudate nucleus , 1979, Brain Research Bulletin.
[28] K. E. Moore,et al. The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs. , 1973, Neuropharmacology.
[29] L. Ganzini,et al. The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. , 1991, Archives of general psychiatry.
[30] D. Sax,et al. Increased frequency of diabetes mellitus in patients with Huntington's chorea. , 1972, Lancet.
[31] M. Trulson,et al. Decreased Brain Dopamine Synthesis Rate and Increased [3H]Spiroperidol Binding in Streptozotocin‐Diabetic Rats , 1983, Journal of neurochemistry.
[32] A. Barbeau,et al. [Clinical experience with tolbutamide in Parkinson's disease]. , 1961, L'union medicale du Canada.
[33] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.
[34] P. Mueller,et al. Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa , 1971, Clinical pharmacology and therapeutics.
[35] W. Malarkey,et al. Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy. , 1974, The Journal of clinical endocrinology and metabolism.
[36] C. Sirtori,et al. Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. , 1972, The New England journal of medicine.
[37] R. Sandyk,et al. The association of diabetes mellitus with dementia in Parkinson's disease. , 1992, The International journal of neuroscience.
[38] R. Håkanson,et al. On the hyperglycaemic effect of DOPA and dopamine. , 1967, European journal of pharmacology.
[39] J. Kepes,et al. Parkinsonism due to a basal ganglia lacunar state , 1990, Neurology.
[40] I. Kopin,et al. Glucose potentiates haloperidol-induced catalepsy. , 1981, Life sciences.
[41] P. Seeman. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes. , 1988, Journal of clinical psychopharmacology.
[42] K. Jellinger,et al. Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.
[43] I. Kopin,et al. Dopamine receptor binding is increased in diabetic rats. , 1981, Science.
[44] H. Sackeim,et al. Possible association between tardive dyskinesia and altered carbohydrate metabolism. , 1985, Archives of general psychiatry.
[45] N. Bathien,et al. Peripheral neuropathies and tremor , 1982, Neurology.
[46] T. Heffner,et al. Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats , 1976, Brain Research.
[47] E. Tolosa,et al. Parkinsonism and basal ganglia infarcts , 1984, Neurology.